Profil
Andrew Marsh worked as the Head of Clinical Development at Ra Pharmaceuticals, Inc. and later as the Head of Development Operations at Synlogic, Inc. He completed his undergraduate degree at Boston University.
Ehemalige bekannte Positionen von Andrew Marsh
| Unternehmen | Position | Ende |
|---|---|---|
| SYNLOGIC, INC. | Corporate Officer/Principal | 01.05.2021 |
| RA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ausbildung von Andrew Marsh
| Boston University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SYNLOGIC, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |